The synergistic effects of Apatinib combined with cytotoxic chemotherapeutic agents on gastric cancer cells and in a fluorescence imaging gastric cancer xenograft model

INTRODUCTION: Methylsulfonic apatinib (hereinafter referred to as Apatinib) is a small-molecule angiogenesis inhibitor highly and selectively targeted to vascular endothelial growth factor receptor-2. At present, a series of basic and clinical studies have confirmed that Apatinib mono-therapy can in...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jiuhuan, Qin, Shukui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975614/
https://www.ncbi.nlm.nih.gov/pubmed/29872316
http://dx.doi.org/10.2147/OTT.S159935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975614/
https://www.ncbi.nlm.nih.gov/pubmed/29872316
http://dx.doi.org/10.2147/OTT.S159935

Ejemplares similares